Although more traditionally known for its tumour-suppressive actions, owing mainly to its growth-halting effect through the inhibition of mTOR signalling and stabilisation of p53, emerging studies have begun to highlight contextual oncogenic roles for AMPK. This evidence concerns the gene PRKAA2 and neoplasm.